Cargando…

Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes

BACKGROUND: Human metapneumovirus (hMPV) causes upper and lower respiratory tract infections (URIs and LRIs, respectively) in healthy and immunocompromised patients; however, its clinical burden in patients with cancer remains unknown. METHODS: In a retrospective study of all laboratory‐confirmed hM...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Chaer, Firas, Shah, Dimpy P., Kmeid, Joumana, Ariza‐Heredia, Ella J., Hosing, Chitra M., Mulanovich, Victor E., Chemaly, Roy F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459658/ https://www.ncbi.nlm.nih.gov/pubmed/28178369 http://dx.doi.org/10.1002/cncr.30599

Ejemplares similares

Active Mycobacterium tuberculosis infection at a comprehensive cancer center, 2006–2014
por: Kmeid, Joumana, et al.
Publicado: (2019)

789. Comparison of Interferon-γ Release Assays (IGRAs) for Diagnosis of Latent or Active Tuberculosis in Cancer Patients
por: Kulkarni, Prathit, et al.
Publicado: (2018)

1561. Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplant
por: Artau, Annette, et al.
Publicado: (2018)

Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies
por: Vakil, Erik, et al.
Publicado: (2018)

Use of Oral Ribavirin for the Treatment of RSV Infections in Hematopoietic Cell Transplant (HCT) Recipients
por: Foolad, Farnaz, et al.
Publicado: (2017)

1120 The Impact of Influenza Vaccination in Patients with Cancer on Subsequent Disease during the 2013-2014 Influenza Season
por: Azzi, Jacques, et al.
Publicado: (2014)

Respiratory Viral Infections in Recipients of Cellular Therapies: A Review of Incidence, Outcomes, Treatment, and Prevention
por: Wilson Dib, Rita, et al.
Publicado: (2023)

How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies
por: El Chaer, Firas, et al.
Publicado: (2022)

Acute and latent viral infections in immunocompromised patients: a tale of brave battles and menacing foes
por: Spallone, Amy, et al.
Publicado: (2022)

Oritavancin for the treatment of acute bacterial skin and skin structure infections: an evidence-based review
por: Kmeid, Joumana, et al.
Publicado: (2015)

1583. The Utility of the Immunodeficiency Scoring Index (ISI) to Predict Outcomes of Coronavirus (HCoV) Infections in Hematopietic Cell Transplant (HCT) Recipients
por: Khawaja, Fareed, et al.
Publicado: (2018)

Utility of the Enzyme-Linked Immunospot Interferon-γ–Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients
por: Nesher, Lior, et al.
Publicado: (2016)

15. Evaluation of Retained Immunity for Tetanus-Diphtheria and Pneumococcal Vaccines in Recipients of Cellular Therapies
por: Angelidakis, Georgios, et al.
Publicado: (2021)

568. Healthcare Cost and Length of Stay for Cytomegalovirus (CMV) Infection-Related Hospitalizations in Allogeneic Hematopoietic Cell Transplant (allo-HCT) recipients: A Multicenter Analysis
por: Khawaja, Fareed, et al.
Publicado: (2020)

940. The use of a commercially available CMV T Cell Immunity Panel to Assess the Risk of CMV Infections in Hematopoietic Cell Transplant Recipients with Low Level CMV Viremia
por: Khawaja, Fareed, et al.
Publicado: (2021)

Human metapneumovirus infection
por: Warris, Adilia, et al.
Publicado: (2007)

2798. Respiratory Viral Infections in Patients with Lymphoma and Multiple Myeloma: Risk Factors Associated with Progression to Lower Respiratory Tract Infection and Mortality
por: Martinez, Daniel De La Rosa, et al.
Publicado: (2019)

922. The Impact of Clinically Significant CMV Infections on Other Viral Infections in the Era of Letermovir Primary Prophylaxis
por: Spallone, Amy, et al.
Publicado: (2021)

Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant
por: Ariza-Heredia, Ella J, et al.
Publicado: (2023)

2119. Predictive Value of the Immunodeficiency Scoring Index for COVID-19 Related Outcomes in Hematopoietic Transplant Recipients
por: Daher, Marilyne, et al.
Publicado: (2022)

Increase Human Metapneumovirus Mediated Morbidity following Pandemic Influenza Infection
por: Regev, Liora, et al.
Publicado: (2012)

1995. Duration of letermovir primary prophylaxis in hematopoietic cell transplant recipients at high risk for cytomegalovirus infections and impact on outcomes
por: Febres-Aldana, Anthony J, et al.
Publicado: (2023)

Human Metapneumovirus Infections in Children
por: Heikkinen, Terho, et al.
Publicado: (2008)

2121. The Impact of Donor CMV Serostatus on Outcomes of CMV Infections in the Era of Letermovir
por: Aramburo, Oscar Morado, et al.
Publicado: (2022)

Hematopoietic stem cell transplantation for the management of follicular lymphoma
por: Hosing, Chitra
Publicado: (2010)

580. Refractory and Resistant CMV Infections in Hematopoietic Cell Transplant Recipients in the Letermovir Primary Prophylaxis Era
por: Sassine, Joseph, et al.
Publicado: (2020)

Human Metapneumovirus Infections in Hospitalized Children
por: Boivin, Guy, et al.
Publicado: (2003)

Human Metapneumovirus
por: Hermos, Christina R., et al.
Publicado: (2010)

Human Metapneumovirus
por: Garcia–Moliner, Maria L.
Publicado: (2013)

Métapneumovirus humain
por: Freymuth, F., et al.
Publicado: (2009)

Pediatric burden and seasonality of human metapneumovirus over 5 years in Managua, Nicaragua
por: Hacker, Kathryn, et al.
Publicado: (2022)

Human metapneumovirus infection in children hospitalized for wheezing
por: Williams, John V., et al.
Publicado: (2005)

Persistent Human Metapneumovirus Infection in Immunocompromised Child
por: Abed, Yacine, et al.
Publicado: (2008)

Human Metapneumovirus Infection among Children, Bangladesh
por: Brooks, W. Abdullah, et al.
Publicado: (2007)

Humoral immunity to human metapneumovirus infection in adults()
por: Falsey, Ann R., et al.
Publicado: (2010)

Dendritic Cells in Human Pneumovirus and Metapneumovirus Infections
por: Guerrero-Plata, Antonieta
Publicado: (2013)

Human Metapneumovirus Infection in Chimpanzees, United States
por: Slater, Owen M., et al.
Publicado: (2014)

Interferon-Mediated Response to Human Metapneumovirus Infection
por: Uche, Ifeanyi K., et al.
Publicado: (2018)

Cell-Mediated Responses to Human Metapneumovirus Infection
por: Ballegeer, Marlies, et al.
Publicado: (2020)

Outbreak of Human Metapneumovirus Infection in Zoo, Slovenia
por: Uršič, Tina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dokt02kptgn24pgjgnrgbkf0a2